Covered recipient · General Payments record
NEBRETTA BLOUNT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$729.90
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $277.83 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Insulet Corporation | $121.44 | 3 |
| DEXCOM, INC. | $25.50 | 1 |
| Abbott Laboratories | $24.61 | 1 |
| Xeris Pharmaceuticals, Inc. | $23.84 | 1 |
| Novo Nordisk AS | $19.66 | 1 |
| MannKind Corporation | $18.87 | 1 |
| Lilly USA, LLC | $18.45 | 1 |
| ABBVIE INC. | $14.04 | 1 |
| CeQur Corporation | $11.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.61 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125218535 | CMS |
| ABBVIE INC. | $14.04 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779097 | CMS |
| CeQur Corporation | $11.42 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099650407 | CMS |
| Dexcom, Inc. | $25.50 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153380974 | CMS |
| Insulet Corporation | $18.61 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116805002 | CMS |
| Insulet Corporation | $79.69 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116805000 | CMS |
| Insulet Corporation | $23.14 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116826264 | CMS |
| Lilly USA, LLC | $18.45 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135850461 | CMS |
| Mannkind Corporation | $18.87 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145852501 | CMS |
| Novo Nordisk Inc | $19.66 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100473538 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.84 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144635962 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.